首页|期刊导航|中药药理与临床|基于网络药理学及实验验证探讨燥湿化痰泻肺方治疗重症肺炎的作用机制

基于网络药理学及实验验证探讨燥湿化痰泻肺方治疗重症肺炎的作用机制OA

Network Pharmacology and Animal Experiments Reveal the Treatment Mechanism of Zaoshi Huatan Xiefei Formula on Severe Pneumonia

中文摘要英文摘要

目的:基于网络药理学结合实验验证,探讨燥湿化痰泻肺方改善肺炎克雷伯菌诱导的重症肺炎的作用机制.方法:基于 TCMSP 数据库获取燥湿化痰泻肺方活性成分及靶点,通过 GeneCards、DisGeNET、OMIM 数据库收集肺炎相关靶点,利用 String 数据库构建关键靶点 PPI 网络图.基于 MetaScape 数据库进行 GO 和 KEGG 分析,使用 PDB 和 CB-Dock 进行分子对接验证.建立肺炎克雷伯菌诱导的重症肺炎小鼠模型,给予燥湿化痰泻肺方灌胃,腹腔注射头孢曲松钠,第3 d 处死小鼠.称小鼠体质量记录死亡率,计算小鼠湿干比;血常规检测小鼠外周血白细胞及中性粒细胞计数;HE 染色观察肺组织病理变化;马松染色观察小鼠肺组织胶原纤维沉积情况;CT检测肺实变范围;ELISA 法测定肺组织及肺泡灌洗液炎症因子含量;流式细胞术检测肺泡灌洗液中性粒细胞比例;免疫组化观察髓过氧化物酶(MPO)、中性粒细胞弹性蛋白酶(NE)和淋巴细胞抗原 6 复合体位点 G(Ly6G)蛋白阳性表达;实时荧光定量 PCR 法检测中性粒细胞趋化因子 mRNA 表达;Western blot 法检测 p-JAK1/JAK1、p-JAK2/JAK2、p-STAT3/STAT3、p-STAT6/STAT6 蛋白表达.结果:筛选出燥湿化痰泻肺方治疗肺炎的活性成分146 个,关键蛋白391 个.GO 分析发现潜在靶点作用于细胞迁移的正调控、蛋白酪氨酸激酶活性、转录调节复合物等生物学过程;KEGG 与肺炎相关的信号通路主要富集于 JAK/STAT 信号通路.动物实验验证结果表明,与正常对照组比较,模型对照组体质量显著降低,死亡率升高,小鼠肺组织肺泡壁增厚,肺泡结构破坏,肺泡及肺间质中伴有大量的炎细胞浸润,肺组织充血水肿,肺损伤及肺泡炎评分显著升高(P<0.01),肺实变范围、肺密度显著增加,胶原纤维沉积显著增加,肺组织及肺泡灌洗液 IL-6、TNF-α 含量明显升高,肺组织 MPO、NE、Ly6G 蛋白阳性表达升高,Cxcl2、Ccl9 mRNA 表达明显上调,肺组织 p-JAK1/JAK1、p-JAK2/JAK2、p-STAT3/STAT3、p-STAT6/STAT6 表达明显上调(P<0.05 或 P<0.01);与模型对照组比较,燥湿化痰泻肺方 9、18 g/kg 组体质量显著升高,死亡率降低,肺泡结构恢复,炎细胞浸润减轻,肺损伤减轻,泡炎评分显著降低(P<0.01),肺实变范围及胶原纤维沉积减少,肺组织及肺泡灌洗液 IL-6、TNF-α 含量明显降低(P<0.05 或 P<0.01),肺泡灌洗液中性粒细胞百分率显著降低(P<0.01),肺组织MPO、NE、Ly6G 蛋白阳性表达水平降低,Cxcl2、Ccl9 mRNA 表达明显下调(P<0.05 或P<0.01),肺组织 p-JAK1/JAK1、p-JAK2/JAK2、p-STAT3/STAT3、p-STAT6/STAT6 表达明显下调(P<0.05 或 P<0.01).结论:燥湿化痰泻肺方可以减少中性粒细胞浸润,抑制炎症反应,改善重症肺炎小鼠模型,其机制与抑制JAK/STAT 信号通路有关.

Objective:To explore the mechanism by which Zaoshi Huatan Xiefei(燥湿化痰泻肺)Formula amelio-rates severe pneumonia induced by Klebsiella pneumoniae based on network pharmacology combined with animal experi-ments.Methods:The active compounds and corresponding targets of Zaoshi Huatan Xiefei Formula were obtained from the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform(TCMSP).Pneumonia-related targets were retrieved from GeneCards,DisGeNET,and OMIM.A protein-protein interaction(PPI)network of key tar-gets was constructed via STRING.Gene Ontology(GO)and Kyoto Encyclopedia of Genes and Genomes(KEGG)path-way enrichment analyses were conducted via MetaScape.PDB and CB-Dock were used for molecular docking validation.A mouse model of severe pneumonia was established by infection with K.pneumoniae.Mice were treated by oral gavage of Zaoshi Huatan Xiefei Formula and intraperitoneal injection of ceftriaxone sodium.Mice were sacrificed on day 3,and then body weight and mortality were recorded.The lung wet/dry weight ratio(mg/mg)was calculated.Peripheral white blood cell and neutrophil counts were determined via routine blood analysis.Hematoxylin and eosin(H&E)staining was employed to observe histopathological changes in the lung tissue,and Masson's trichrome staining to assess collagen fiber deposition.The extent of pulmonary consolidation was evaluated by computed tomography(CT).The levels of inflamma-tory cytokines in the lung tissue and bronchoalveolar lavage fluid(BALF)were measured by enzyme-linked immunosor-bent assay.The proportion of neutrophils in the BALF was analyzed via flow cytometry.Immunohistochemistry was adopted to detect the expression of myeloperoxidase(MPO),neutrophil elastase(NE),and lymphocyte antigen 6 com-plex,locus G(Ly6G).The expression of neutrophil chemokines was determined by qRT-PCR,and the protein levels of phosphorylated(p)-Janus kinase 1(JAK1),p-JAK2,p-signal transducer and activator of transcription 3(STAT3),and p-STAT6 were assessed by Western blotting.Results:A total of 146 active compounds and 391 key targets of Zaoshi Huatan Xiefei Formula were identified for the treatment of pneumonia.GO enrichment analysis revealed that the potential targets were mainly involved in biological processes such as the positive regulation of cell migration,protein tyrosine ki-nase activity,and transcription regulator complex.KEGG pathway enrichment indicated that pneumonia-related signaling pathways were primarily concentrated in the JAK/STAT signaling pathway.Animal experiments demonstrated that com-pared with the normal control group,the model control group showed a continuous and significant decrease in body weight and an increase in mortality.Compared with the model control group,Zaoshi Huatan Xiefei Formula(9 g/kg and 18 g/kg)groups exhibited increased body weight,reduced mortality,thickened alveolar walls,destruction of alveolar structures,massive inflammatory cell infiltration in alveolar and interstitial regions,lung congestion and edema,increased lung injury and alveolitis scores(P<0.01),increased lung consolidation area,density,and collagen fiber deposition,ele-vated levels of interleukin(IL)-6 and tumor necrosis factor(TNF)-α in the lung tissue and BALF,increased expression of MPO,NE,Ly6G,CXCL2,and CCL9,and up-regulated protein levels of p-JAK1,p-JAK2,p-STAT3,and p-STAT6 in the lung tissue(P<0.05 or P<0.01).Compared with the model control group,Zaoshi Huatan Xiefei Formula(9 g/kg and 18 g/kg)groups exhibited improved alveolar structure,reduced inflammatory infiltration,lowered lung injury and al-veolitis scores(P<0.01),ameliorated pulmonary consolidation and collagen fiber deposition,declined levels of IL-6 and TNF-α in the lung tissue and BALF(P<0.05 or P<0.01),decreased proportion of neutrophils in BALF(P<0.01),re-duced expression of MPO,NE,Ly6G,CXCL2,and CCL9 in the lung tissue(P<0.05 or P<0.01),and down-regulated protein levels of p-JAK1,p-JAK2,p-STAT3,and p-STAT6 in the lung tissue(P<0.05 or P<0.01).Conclusion:Zaoshi Huatan Xiefei Formula can reduce neutrophil infiltration,inhibit inflammation,and ameliorate pathological conditions in the mouse model of severe pneumonia by inhibiting the JAK/STAT signaling pathway.

赵帅军;程思远;万冉;程俞梦;单柏溪;赵鹏;李建生

河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学第一附属医院,郑州 450046||河南中医药大学第一临床医学院,郑州 450046河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学第一附属医院,郑州 450046||河南中医药大学第一临床医学院,郑州 450046河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学第一附属医院,郑州 450046||河南中医药大学第一临床医学院,郑州 450046河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学第一附属医院,郑州 450046||河南中医药大学第一临床医学院,郑州 450046河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学中医药科学院,郑州 450046河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学中医药科学院,郑州 450046河南中医药大学呼吸疾病中医药防治省部共建协同创新中心,河南省中医药防治呼吸病重点实验室,郑州 450046||河南中医药大学第一附属医院,郑州 450046||河南中医药大学第一临床医学院,郑州 450046

燥湿化痰泻肺方重症肺炎网络药理学Janus激酶-信号转导及转录激活因子信号通路

Zaoshi Huatan Xiefei FormulaSevere pneumoniaNetwork pharmacologyJanus kinase(JAK)/signal transducer and activator of transcription(STAT)signaling pathway

《中药药理与临床》 2026 (3)

27-36,106,11

河南省高校科技创新人才支持计划(编号:24HASTIT073)河南省本科高校青年骨干教师培养计划(编号:2023GGJS084)河南省高等学校重点科研项目(编号:24A360013).

评论